Is Inflammatory Bowel Disease (IBD) an Autoimmune Condition?


Inflammatory Bowel Disease (IBD) encompasses two chronic conditions causing long-lasting inflammation in your gastrointestinal (GI) tract: Crohn’s disease and ulcerative colitis. According to the Centers for Disease Control and Prevention (CDC), about 1.3 percent of adults in the United States had IBD in 2015, translating to roughly 3 million people.

Researchers have yet to pinpoint the exact cause of IBD. However, it's clear that a dysfunctional immune response leads to the elevated levels of inflammation in the GI tract. So, is IBD an autoimmune disease? While it shares similarities with autoimmune diseases, IBD is somewhat different. Let's dive deeper into IBD, the immune system, and what we know so far.

What is an Autoimmune Disease?

Your immune system defends you from harmful germs and other potentially dangerous substances in your environment. It activates when it detects something in the body that it doesn't recognize as "self," known as an antigen. Once an antigen is identified, the immune system generates a response to neutralize the potential threat before it can cause harm.

However, sometimes the immune system malfunctions and mistakenly attacks healthy tissues, leading to autoimmune disease. Over 80 autoimmune diseases have been identified, according to the National Institute of Environmental Health Sciences. Some well-known examples include:

IBD and the Immune System

IBD falls under the category of immune-mediated inflammatory diseases (IMIDs). IMIDs are conditions where chronic inflammation occurs due to an atypical immune response. Besides IBD, autoimmune diseases are another type of IMID. Asthma and other allergic conditions can also be classified as IMIDs.

Autoimmune diseases are characterized by an inappropriate immune response to healthy organs and tissues. For instance, many people with RA have autoantibodies that attack healthy joint tissue. IBD is a bit different.

IBD is generally believed to be caused by an abnormal immune response to environmental triggers in a genetically susceptible person. This results in chronic inflammation in the GI tract and the symptoms of IBD, which may include:

What’s Up with the Immune System?

Your GI tract contains many potential antigens, including the food you eat, some medications, and healthy bacteria known as commensals. Commensals are crucial for GI health; they aid digestion and protect your GI tract from harmful germs. They also play a role in the development of the immune system.

Usually, your immune system tolerates these factors, recognizing them as harmless and leaving them alone. However, in IBD, a trigger causes the immune system to mount a response against typically harmless factors, such as commensals. This leads to persistent inflammation in the affected part of the GI tract.

In IBD, the lining of the GI tract becomes compromised. Immune cells flood into the area in an effort to eliminate what is mistakenly seen as a threat, causing further inflammation and damage. An imbalance of bacteria, called dysbiosis, also occurs in people with IBD. Whether dysbiosis is a cause or effect of IBD is unknown, but changes in the types of bacteria in the GI tract can also influence immune activity and inflammation.

Causes of IBD

As mentioned earlier, the exact cause of IBD remains unclear. It appears to be a complex combination of immune response, genetics, and environmental factors. Let's explore genetics and environmental factors further.

Genetics

Your individual genetics can predispose you to developing IBD. A 2019 research review notes that first-degree relatives of people with IBD can have up to a five times greater risk of developing IBD themselves. This means that if a close family member, like a parent or sibling, has IBD, you may be at an increased risk of developing it yourself.

Researchers have identified several genes associated with IBD. Many of these genes are related to processes important for the development of chronic inflammation in the GI tract, including:

  • Immune system regulation
  • Maintenance of the GI tract lining
  • Oxidative stress
  • Antimicrobial defenses

Environmental Factors

A 2019 study found that the prevalence of IBD worldwide increased significantly between 1990 and 2017, with the highest increases in high-income countries like the United States and the United Kingdom. This suggests that certain environmental risk factors may trigger or contribute to IBD in genetically susceptible individuals. Some environmental factors associated with IBD risk include:

Does IBD Increase the Risk of Autoimmune Disease?

Both IBD and autoimmune diseases are IMIDs. Given their overlapping mechanisms, could having IBD increase your risk of developing an autoimmune disease? While more studies are needed, some research suggests that having IBD does increase the risk of autoimmune diseases.

For instance, a 2016 study found that individuals with IBD had a higher incidence of autoimmune diseases compared to those without IBD. Severe IBD was associated with a higher risk of developing autoimmune diseases. Similarly, a 2017 study found that 20 different IMIDs were more common in people with IBD, including:

Treatment and Management of IBD

The goal of IBD treatment is to reduce inflammation in the GI tract, maintaining remission and preventing disease progression. Medications are often a critical part of IBD treatment. Several types of medications may be used, including:

  • Aminosalicylates: Drugs like mesalamine and sulfasalazine reduce inflammation in the lining of the intestines.
  • Corticosteroids: Medications like prednisone help control inflammation but are typically used for short-term relief due to potential side effects.
  • Immunosuppressant Drugs: These include azathioprine and 6-mercaptopurine, which suppress the immune system to reduce inflammation.
  • Biologics: Medications like adalimumab (Humira) and infliximab (Remicade) target specific components of the immune system to prevent inflammation.

Other Interventions for Managing IBD

In addition to medications, other interventions can help manage IBD, including:

  • Bowel Rest: For severe Crohn’s disease, a period of bowel rest may be recommended to allow the intestines to heal.
  • Surgery: In some cases, surgery to remove severely affected parts of the GI tract may be necessary.
  • Dietary Adjustments: These may include avoiding foods that trigger symptoms, eating smaller meals more frequently, and using nutritional supplements if you're not receiving enough nutrients.

The Endnote

IBD is an immune-mediated disease that causes chronic inflammation in the GI tract. Without treatment, it can continue to damage the GI tract and lead to serious complications. The exact cause of IBD is still unknown, but it appears to be caused by an abnormal immune response to an environmental trigger in genetically predisposed individuals.

Current treatments for IBD focus on reducing inflammation in the GI tract, which can lead to remission of symptoms. Adhering to your treatment plan is crucial for maintaining remission and preventing progression of the disease.

Conclusion

Inflammatory Bowel Disease is a complex condition involving an abnormal immune response leading to chronic inflammation in the GI tract. While it shares similarities with autoimmune diseases, IBD is distinct in its cause and effect. Understanding the intricate relationship between genetics, environmental factors, and the immune system is key to managing IBD effectively. By following your treatment plan and making necessary lifestyle adjustments, you can manage symptoms and improve your quality of life. Always consult with healthcare professionals for guidance tailored to your specific needs.


Also Read:

Breast Cancer

0 Comments